Theravance Biopharma Inc
XNAS:TBPH 4:00:00 PM EDT
| Market Cap (Intraday) | 766.50M |
| Current PE | 58.83 |
| Forward PE | 10.15 |
| 2yr Forward PE | 50.73 |
| 10-Day MA | $14.45 |
| 50-Day MA | $14.12 |
| 200-Day MA | $11.12 |
Theravance Biopharma Inc Stock, XNAS:TBPH
901 Gateway Boulevard, South Church Street, South San, California 94080
Cayman Islands
Phone: +1.650.808.6000
Number of Employees: 97
Description
Theravance Biopharma, Inc. is a biopharmaceutical company, which engages in the discovery, research, development, and commercialization of respiratory medicines. It operates through the U.S. and Europe geographical segments. Its products include telavancin under the VIBATIV brand, revefenacin under the TD 4208 brand, and neprilysin. The company was founded in July 2013 and is headquartered in George Town, Cayman Islands.